Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$0.26 CAD
Change Today -0.03 / -10.53%
Volume 43.6K
As of 1:27 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by GENENEWS LTD (GEN) in the last 6 months

Announced 08/19/15
1.00M for GeneNews Limited
Private Placement

GeneNews Limited (TSX:GEN) announced a non-brokered private placement of 3,956,249 units at a price of CAD 0.32 per unit for gross proceeds of CAD 1,265,999.68 on August 19, 2015. Each unit consists of one common share and one share purchase warrant. Each warrant entitles the holder to purchase one common share of the company at an exercise price of CAD 0.50 per share and exercisable until September 15, 2017. Rory Riggs has subscribed 1,562,500 units in the transaction. ...
Read More


GEN's price was unchanged after the transaction was announced on 08/19/15.
 
Announced 07/15/15
3.00M for GeneNews Limited
Private Placement

GeneNes Limited (TSX:GEN) announced a non-brokered private placement of 8,668,240 units at a price of CAD 0.35 per unit for gross proceeds of CAD 3,033,884 on July 15, 2015. Each unit is comprised of one common share and one-half warrant. Each whole warrant entitles the holder to purchase one common share at an exercise price of CAD 0.50 for a period of 1 year following the date of issue, subject to customary adjustment provisions. Certain insiders of the company have ...
Read More


GEN's price was unchanged after the transaction was announced on 07/15/15.
 
Announced 05/19/15
4.00M for Innovative Diagnostic Laboratory, LLP
Merger/Acquisition

Cobalt Healthcare Consultants, Inc. and GeneNews Limited (TSX:GEN) acquired 33.33% stake in Innovative Diagnostic Laboratory, LLP (IDL) from Health Diagnostic Laboratory, Inc. (HDL) for $4 million in cash and promissory notes on May 15, 2015. The purchase price payable by each of GeneNews and Cobalt will be satisfied in part with each company issuing a one-year secured promissory note in the principal amount of $1 million and the balance of the purchase price to be paid ...
Read More


GEN's price was unchanged after the transaction was announced on 05/19/15.
Investor / Buyer
Cobalt Healthcare Consultants, Inc.
GeneNews Limited
Creditor / Lender
Health Diagnostic Laboratory, Inc.
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GEN:CN C$0.26 CAD -0.03

GEN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for GEN.
View Industry Companies
 

Industry Analysis

GEN

Industry Average

Valuation GEN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.5x
Price/Book 10.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENENEWS LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.